(1 - 7 von 11
)
GSK and Ranbaxy's extension of R&D pact is 'win-win' - PharmaTimes
www.pharmatimes.com
GlaxoSmithKline and Ranbaxy Laboratories have signed a new R&D alliance which could be worth over $100 million to the Indian drugmaker. - News - PharmaTimes
sortiert nach Relevanz / Datum